Allina Health System
Allina Health System sponsors 32 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 27 completed. 3 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Local Anesthesia for Peripheral Intravenous Catheterization, with 1 trials.
Trial Pipeline
32 total, page 1 of 1
Utility of Intermittent Cryo-Compression Versus Traditional Icing Following Arthroscopic Rotator Cuff Repair
NCT05095909
Compass Course: COVID-19
NCT05295238
SENSE Study: Remote Symptom Monitoring for Patients With Chemotherapy-induced Peripheral Neuropathy
NCT05330104
Problem-Solving Therapy for Depressive Symptoms and Quality of Life in Stroke Survivor-Caregiver Dyads
NCT04035681
Manual Wheelchair Speed, Maneuverability, and Endurance and Community Access
NCT03469414
Validation of Readiband™ Actigraph and Associated Sleep/Wake Classification Algorithms
NCT03877861
Compass Course: Efficacy Study
NCT03442686
Narrow QRS HF Patients Assessed by ECG Belt
NCT03367104
Dual-task Assessment and Rehabilitation for Individuals With Residual Symptoms After mTBI
NCT03478059
PLAY LONG: The Effect of Sports and Recreation Participation for Young chiLdren With physicAl disabilitY
NCT03256318
Purpose Project: Reclaiming Life Purpose After Breast Cancer (Feasibility Study)
NCT03233334
Activity Based Locomotor Exercise PrOgram-Wait-list controllEd Research
NCT03261388
Cognitive Rehabilitation:ACTION Training for Soldiers With Executive Dysfunction
NCT02352441
Behavior of Cyclists in Response to Pain
NCT03704883
Acupuncture in the Emergency Department
NCT02888340
Low-Dose Radiation Therapy to the Whole Liver With Gemcitabine and Cisplatin in IHC
NCT02254681
A Pilot Trial to Assess the Impact of Acupuncture on Post-mastectomy Pain, Nausea, Anxiety and Ability to Cope
NCT02122796
Impact of Prehabilitation in Total Knee Replacement
NCT01844934
Stress Reduction for Busy Professionals
NCT02194478
Sit to Stand Intervention for Allina Health Employees
NCT02206113
The Effects of Lavender Aromatherapy on Reducing Stress and Anxiety During MRI Procedures.
NCT01809067
Local Anesthetics for Pain Reduction Prior to IV Line Placement
NCT01759459
LifeCourse: A Supportive Care Approach for Patients Late in Life
NCT01746446
Results From a Health System-wide Implementation of a Quality of Life Questionnaire
NCT02906423
The Effect of Gum Chewing on Bowel Motility in Post-operative Colon Resection Patients
NCT01613274
Palliative Care for Heart Failure Patients
NCT01519479
Metabolic Syndrome and Insulin Resistance at Allina
NCT01545830
Effect of Complementary and Alternative Medicine on Pain Among Inpatients
NCT02190240
Response to Cardiac Resynchronization Therapy of Previously Right Ventricular Paced Heart Failure Patients
NCT01466621
Perioperative Pain Management In Spine Surgery Patients: Part I
NCT01447888
Care Guides in the Primary Care Office (Phase II)
NCT01156974
Raltegravir Kaletra Pharmacokinetics
NCT00564772
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
| Phase 3 | 1 |
| Phase 4 | 2 |
What the Pipeline for Allina Health System Shows
According to the ClinicalTrials.gov registry, Allina Health System is linked to 32 US clinical trials across every stage of research activity. Of those, 1 studies are currently recruiting, about 3% of the sponsor's indexed portfolio, and 27 are already marked complete, representing roughly 84% of the total.
The phase mix for Allina Health System reports 3 late-stage studies (Phase 3 and Phase 4 combined) and 3 earlier-phase studies (Phase 1 and Phase 2).
The top therapeutic focus area indexed for Allina Health System is Local Anesthesia for Peripheral Intravenous Catheterization with 1 linked trial, and 9 other condition areas appear in the top list above.
How to read these pipeline numbers
Recruiting share is one of the more practical signals here: it reflects how much of a sponsor's research is presently open to new participants, while the completed share indicates the depth of finished work that has already contributed registry results. Both counts come directly from the public ClinicalTrials.gov dataset and are refreshed on the registry side; this page mirrors the latest data pull without altering it.
A portfolio weighted toward Phase 3 usually reflects an organization advancing candidates toward regulatory review, where the research centers on comparative efficacy and broader safety across larger populations. A heavier Phase 1 and Phase 2 tilt generally indicates exploratory work, safety, dosing, and early signal detection, and is common among research-forward sponsors that seed many early programs. Phase 4 entries, when present, track interventions already in real-world use and typically focus on long-term safety, effectiveness across subgroups, or formulation comparisons.
That distribution is a quick read of where the organization concentrates its research attention; it does not imply product availability, market share, or any clinical endorsement. All numbers on this page come from ClinicalTrials.gov maintained by the National Library of Medicine, and counts can shift as new studies are registered or existing ones update their status. This information is provided for reference and educational purposes only, not as medical, investment, or regulatory advice, verify current details directly with ClinicalTrials.gov before relying on any figure here.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.